Research published in the New Zealand Medical Journal on 9 October 2020 clearly points to the need to reconsider the current inconsistent approach to prostate cancer screening for Kiwi men.[i]
Prostate cancer is the leading cancer diagnosed in New Zealand men and the numbers have increased by over 25% in the last five years, with nearly 4000 men diagnosed in 2019.
The Prostate Cancer Foundation shares significant concerns that are highlighted in this recent research. While there has been a general understanding that numbers receiving PSA testing have been relatively low, based on earlier studies, this new research shows that despite there not being an organized screening programme, prostate cancer testing rates (65% for men 50-69 years) are comparable to current national targets for breast (70%) and colorectal (62%) cancer screening programmes. Read More